首页> 外文期刊>Blood: The Journal of the American Society of Hematology >A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era.
【24h】

A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era.

机译:老年霍奇金淋巴瘤的回顾性多中心分析:现代时代的结果和预后因素。

获取原文
获取原文并翻译 | 示例
           

摘要

We investigated a recent (January 1999 to December 2009) cohort of 95 elderly Hodgkin lymphoma subjects. At diagnosis, median age was 67 years (range, 60-89 years), whereas 61% had significant comorbidity, 26% were unfit, 17% had a geriatric syndrome, and 13% had loss of activities of daily living. Overall response rate to therapy was 85%, whereas incidence of bleomycin lung toxicity was 32% (with associated mortality rate, 25%). With 66-month median follow-up, 2-year and 5-year overall survival were 73% and 58%, respectively (advanced-stage, 63% and 46%, respectively). Most International Prognostic Score factors were not prognostic on univariate analyses, whereas Cox multivariate regression identified 2 risk factors associated with inferior overall survival: (1) age more than 70 years (2.24; 95% CI, 1.16-4.33, P = .02) and (2) loss of activities of daily living (2.71; 95% CI, 1.07-6.84, P = .04). Furthermore, a novel survival model based on number of these risk factors (0, 1, or 2) showed differential 2-year OS of 83%, 70%, and 13%, respectively (P < .0001) and 5-year OS of 73%, 51%, and 0%, respectively (P < .0001).
机译:我们调查了最近(1999年1月至2009年12月)的95位老年霍奇金淋巴瘤受试者的队列。在诊断时,中位年龄为67岁(范围为60-89岁),而61%患有严重合并症,26%不适合,17%患有老年综合症和13%丧失日常生活能力。总体治疗反应率为85%,博来霉素肺毒性的发生率为32%(相关死亡率为25%)。经过66个月的中位随访,2年和5年总生存率分别为73%和58%(高级阶段分别为63%和46%)。大多数国际预后评分因素对单因素分析均无预后,而Cox多因素回归确定了2种与总体生存不良相关的危险因素:(1)年龄超过70岁(2.24; 95%CI,1.16-4.33,P = .02) (2)丧失日常活动(2.71; 95%CI,1.07-6.84,P = .04)。此外,基于这些危险因素数量(0、1或2)的新型生存模型显示2年差异OS分别为83%,70%和13%(P <.0001)和5年OS分别为73%,51%和0%(P <.0001)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号